An early-phase development activity involving the investigation of multiple synthetic pathways to identify the most efficient, scalable, and economically viable route for manufacturing a new Active Pharmaceutical Ingredient.
Meet Neuland at CPHI India 2026 | Hall 2, Booth 2D38 | Yashobhoomi Convention Centre, New Delhi | 24-26 November 2026 Schedule a Meeting

Explore how Neuland supports API programs from pre-IND through commercial manufacturing.